Bronchiolitis obliterans syndrome (BOS) is the most important factor limiting long-term survival after lung transplantation, and has a substantial impact on patients' daily life in terms of disability and morbidity. Aim of our study was to examine the effects of BOS on health related quality of life (HRQL) in lung transplantation patients. Data on HRQL from 29 patients who developed BOS at least 18 months earlier were studied longitudinally. HRQL measures were: the Nottingham Health Profile (NHP), the State Trait Anxiety Inventory (STAI), the Self-rating Depression Scale (ZUNG), and the Index of Well Being (IWB). Furthermore questions concerning activities of daily life and dyspnea were asked. The majority of the patients were male, and the...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
Lung transplantation (LT) increases the life expectancy of patients affected by end stage pulmonary ...
Study objectives: The influence of bronchiolitis obliterans syndrome (BOS) on costs after lung trans...
Bronchiolitis obliterans syndrome (BOS) is the most important factor limiting long-term survival aft...
The present study was undertaken to assess the relationship between health-related quality of life (...
BACKGROUND: Outcome after lung transplantation (LTx) is affected by the onset of bronchiolitis oblit...
BACKGROUND: Outcome after lung transplantation (LTx) is affected by the onset of bronchiolitis oblit...
Introduction Bronchiolitis obliterans (BO) is mainly caused by infections and hematopoietic stem cel...
The aim of this study was to examine the long-term effect of lung transplantation on Health Related ...
Study objectives: To assess the change in health-related quality of life (HRQL) among Dutch lung tra...
STUDY OBJECTIVES: To assess the change in health-related quality of life (HRQL) among Dutch lung tra...
INTRODUCTION: Bronchiolitis Obliterans Syndrome (BOS) is a debilitating disease with limited treatme...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
Background: Lung transplantation has proven to be an effective treatment option for patients with en...
Background: Lung transplantation has proven to be an effective treatment option for patients with en...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
Lung transplantation (LT) increases the life expectancy of patients affected by end stage pulmonary ...
Study objectives: The influence of bronchiolitis obliterans syndrome (BOS) on costs after lung trans...
Bronchiolitis obliterans syndrome (BOS) is the most important factor limiting long-term survival aft...
The present study was undertaken to assess the relationship between health-related quality of life (...
BACKGROUND: Outcome after lung transplantation (LTx) is affected by the onset of bronchiolitis oblit...
BACKGROUND: Outcome after lung transplantation (LTx) is affected by the onset of bronchiolitis oblit...
Introduction Bronchiolitis obliterans (BO) is mainly caused by infections and hematopoietic stem cel...
The aim of this study was to examine the long-term effect of lung transplantation on Health Related ...
Study objectives: To assess the change in health-related quality of life (HRQL) among Dutch lung tra...
STUDY OBJECTIVES: To assess the change in health-related quality of life (HRQL) among Dutch lung tra...
INTRODUCTION: Bronchiolitis Obliterans Syndrome (BOS) is a debilitating disease with limited treatme...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
Background: Lung transplantation has proven to be an effective treatment option for patients with en...
Background: Lung transplantation has proven to be an effective treatment option for patients with en...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
Lung transplantation (LT) increases the life expectancy of patients affected by end stage pulmonary ...
Study objectives: The influence of bronchiolitis obliterans syndrome (BOS) on costs after lung trans...